Interestingly, inhibition or knockdown of RSK prevented EphA2-S897 phosphorylation, leading to a signaling shift to the canonical tumor-suppressive tyrosine phosphorylation and consequent downregulation of EphA2 [41]. Here, EPHA2 is linked to neoplasm.